![John Lunger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Lunger
No más puestos en curso
Fortuna: 1 776 $ al 31/05/2026
Perfil
John Lunger formerly worked at Genocea Biosciences, Inc., as Independent Director, Merrimack Pharmaceuticals, Inc., as Head-Supply Chain & Commercial Product Supply, and Adaptimmune Therapeutics Plc, as Chief Patient Supply Officer from 2019 to 2025.
Mr. Lunger received his undergraduate degree from United States Naval Academy and Masters Business Admin degree from The University of Chicago Booth School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/04/2025 | 1.025.340 ( 0,06 % ) | 1 025 $ | 31/05/2026 | |
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes 0,16 % | 17/01/2025 | 7.510 ( 0,16 % ) | 751 $ | 31/05/2026 |
Antiguos cargos conocidos de John Lunger.
| Empresas | Cargo | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 29/08/2025 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Director/Miembro de la Junta | - |
Formación de John Lunger.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
13
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
- Bolsa de valores
- Insiders
- John Lunger
